Evidence map›Paper›PMID 39199562›Full record

ReviewCancers2024

The Impact of Biliary Injury on the Recurrence of Biliary Cancer and Benign Disease after Liver Transplantation: Risk Factors and Mechanisms.

Chase J Wehrle, Rebecca Panconesi, Sangeeta Satish, Marianna Maspero, Chunbao Jiao, Keyue Sun, Omer Karakaya, Erlind Allkushi, Jamak Modaresi Esfeh, Maureen Whitsett Linganna and 7 more

Abstract readReview
In one paragraph

Review in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Chase J WehrleTransplantation Center, Cleveland Clinic, Cleveland, OH 44195, USA.ORCID 0000-0002-9275-4744
Rebecca PanconesiDepartment of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.ORCID 0000-0003-2708-1261
Sangeeta SatishTransplantation Center, Cleveland Clinic, Cleveland, OH 44195, USA.
Marianna MasperoGeneral Surgery and Liver Transplantation Unit, IRCCS Istituto Tumori, 20133 Milan, Italy.ORCID 0000-0002-7589-4489
Chunbao JiaoDepartment of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.ORCID 0000-0002-9566-8243
Keyue SunDepartment of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.ORCID 0000-0002-8928-4630
Omer KarakayaDepartment of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Erlind AllkushiTransplantation Center, Cleveland Clinic, Cleveland, OH 44195, USA.
Jamak Modaresi EsfehDepartment of Gastroenterology and Transplant Hepatology, Cleveland Clinic, Cleveland, OH 44195, USA.ORCID 0000-0002-9429-5465
Maureen Whitsett LingannaDepartment of Gastroenterology and Transplant Hepatology, Cleveland Clinic, Cleveland, OH 44195, USA.
Wen Wee MaNovel Therapeutics Center, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH 44195, USA.ORCID 0000-0001-5899-4034
Masato FujikiTransplantation Center, Cleveland Clinic, Cleveland, OH 44195, USA.ORCID 0000-0002-1118-0081
Koji HashimotoTransplantation Center, Cleveland Clinic, Cleveland, OH 44195, USA.
Charles MillerTransplantation Center, Cleveland Clinic, Cleveland, OH 44195, USA.
David C H KwonTransplantation Center, Cleveland Clinic, Cleveland, OH 44195, USA.
Federico AucejoTransplantation Center, Cleveland Clinic, Cleveland, OH 44195, USA.
Andrea SchlegelTransplantation Center, Cleveland Clinic, Cleveland, OH 44195, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver transplantation is known to generate significant inflammation in the entire organ based on the metabolic profile and the tissue's ability to recover from the ischemia-reperfusion injury (IRI). This cascade contributes to post-transplant complications, affecting both the synthetic liver function (immediate) and the scar development in the biliary tree. The new occurrence of biliary strictures, and the recurrence of malignant and benign liver diseases, such as cholangiocarcinoma (CCA) and primary sclerosing cholangitis (PSC), are direct consequences linked to this inflammation. The accumulation of toxic metabolites, such as succinate, causes undirected electron flows, triggering the releases of reactive oxygen species (ROS) from a severely dysfunctional mitochondrial complex 1. This initiates the inflammatory IRI cascade, with subsequent ischemic biliary stricturing, and the upregulation of pro-tumorigenic signaling. Such inflammation is both local and systemic, promoting an immunocompromised status that can lead to the recurrence of underlying liver disease, both malignant and benign in nature. The traditional treatment for CCA was resection, when possible, followed by cytotoxic chemotherapy. Liver transplant oncology is increasingly recognized as a potentially curative approach for patients with intrahepatic (iCCA) and perihilar (pCCA) cholangiocarcinoma. The link between IRI and disease recurrence is increasingly recognized in transplant oncology for hepatocellular carcinoma. However, smaller numbers have prevented similar analyses for CCA. The mechanistic link may be even more critical in this disease, as IRI causes the most profound damage to the intrahepatic bile ducts. This article reviews the underlying mechanisms associated with biliary inflammation and biliary pathology after liver transplantation. One main focus is on the link between transplant-related IRI-associated inflammation and the recurrence of cholangiocarcinoma and benign liver diseases of the biliary tree. Risk factors and protective strategies are highlighted.

Indexed as

benign disease recurrencebiliary complicationscholangiocarcinomaliver transplantation

Identifiers

PMID39199562
PMCPMC11352383

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.